1. Home
  2. CVGI vs GNLX Comparison

CVGI vs GNLX Comparison

Compare CVGI & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$5.27

Market Cap

121.8M

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.88

Market Cap

113.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
GNLX
Founded
2000
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
121.8M
113.6M
IPO Year
2004
2022

Fundamental Metrics

Financial Performance
Metric
CVGI
GNLX
Price
$5.27
$2.88
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$17.25
AVG Volume (30 Days)
521.1K
152.8K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
316.18
9.47
EPS
0.04
N/A
Revenue
$755,231,000.00
$8,000.00
Revenue This Year
$4.84
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$130.88
N/A
Revenue Growth
14.06
N/A
52 Week Low
$1.25
$2.29
52 Week High
$5.50
$8.54

Technical Indicators

Market Signals
Indicator
CVGI
GNLX
Relative Strength Index (RSI) 72.22 55.87
Support Level $1.51 $2.36
Resistance Level N/A $2.97
Average True Range (ATR) 0.38 0.19
MACD 0.07 0.04
Stochastic Oscillator 83.67 52.64

Price Performance

Historical Comparison
CVGI
GNLX

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: